Page 10-33
excess cancer incidence per unit intake for the
radionuclides of concern. The Integrated Risk
Information System (IRIS) contains slope factor
values for radionuclides of concern at remedial
sites for each of the four major exposure
pathways (inhalation, ingestion, air immersion,
and ground-surface irradiation), along with
supporting documentation for the derivation of
these values (see Chapter 7 for more detail on
IRIS).
The slope factors from the IRIS data base
for the inhalation pathway should be multiplied
by the estimated inhaled activity (derived using
the methods presented in Section 6.6.3 and
Exhibit 6-16, without division of the body
weight and averaging time) for each
radionuclide of concern to estimate risks from
the inhalation pathway. Similarly, risks from the
ingestion pathway should be estimated by
multiplying the ingestion slope factors by the
activity ingested for each radionuclide of
concern (derived using the methods presented in
Exhibits 6-11, 6-12, 6-14, 6-17, 6-18, and 6-19,
without division by the body weight and
averaging time). Estimates of the risk from the
air immersion pathway should be computed by
multiplying the appropriate slope factors by the
airborne radionuclide concentration (Bq/m
3
) and
the duration of exposure. Risk from the ground
surface pathway should be computed as the
product of the slope factor, the soil
concentration (Bq/m
2
), and the duration of
exposure for each radionuclide of concern.
The sum of the risks from all
radionuclides and pathways yields the lifetime
risk from the overall exposure. As discussed in
Chapter 8, professional judgment must be used
in combining the risks from various pathways,
as it may not be physically possible for one
person to be exposed to the maximum
radionuclide concentrations for all pathways.
10.7.3 COMBINING RADIONUCLIDE AND
CHEMICAL CANCER RISKS
Comment [A68]: EPA has updated its
recommendation concerning the summing of
radiation cancer risks and chemical cancer risks.
As stated in its December 1999 document
Radiation Risk Assessment at CERCLA Sites:
Q&A
(see Q28, page 11), “[e]xcess cancer risk
from both radionuclides and chemical
carcinogens should be summed to provide an
estimate of the combined risk presented by all
carcinogenic contaminants. An exception would
be cases in which a person reasonably cannot
be exposed to both chemical and radiological
carcinogens. Similarly, the chemical toxicity
from uranium should be combined with that of
other site-related contaminants.” While there
are differences between slope factors for
radionuclides and chemicals, similar differences
also occur between different chemical slope
factors. In the absence of additional
information, it is reasonable to assume that
excess cancer risks are additive when
evaluating the total incremental cancer risk
associated with contaminated sites.
EPA continues to recommend that risk
estimates for radionuclides and chemical
contaminants also be tabulated and presented
separately in the risk characterization report.
The Radiation Risk Assessment Q&A may be
found at:
http://www.epa.gov/superfund/health/contamin
ants/radiation/pdfs/riskqa.pdf
Estimates of the lifetime risk of cancer to
exposed individuals resulting from radiological
and chemical risk assessments may be summed
in order to determine the overall potential human
health hazard associated with a site. Certain
precautions should be taken, however, before
summing these risks. First, the risk assessor
should evaluate whether it is reasonable to
assume that the same individual can receive the
maximum radiological and chemical dose. It is
possible for this to occur in some cases because
many of the environmental transport processes
and routes of exposure are the same for
radionuclides and chemicals.
In cases where different environmental
fate and transport models have been used to
predict chemical and radionuclide exposure, the
mathematical models may incorporate somewhat
different assumptions. These differences can
result in incompatibilities in the two estimates of
risk. One important difference of this nature is
how the cancer toxicity values (i.e., slope
factors) were developed. For both radionuclides
and chemicals, cancer toxicity values are
obtained by extrapolation from experimental and
epidemiological data. For radionuclides,
however, human epidemiological data form the
basis of the extrapolation, while for many
chemical carcinogens, laboratory experiments
are the primary basis for the extrapolation.
Another even more fundamental difference
between the two is that slope factors for
chemical carcinogens generally represent an
upper bound or 95th percent confidence limit
value, while radionuclide slope factors are best
estimate values.
In light of these limitations, the two sets of
risk estimates should be tabulated separately in
the final baseline risk assessment.
10.7.4 ASSESSING AND PRESENTING
UNCERTAINTIES
Uncertainties in the risk assessment must
be evaluated and discussed, including
uncertainties in the physical setting definition
for the site, in the models used, in the exposure
parameters, and in the toxicity assessment.
Monte Carlo uncertainty analyses are frequently
performed as part of the uncertainty and
sensitivity analysis for radiological risk
assessments. A summary of the use of
uncertainty analyses in support of radiological
risk assessments is provided in NCRP Report
No. 76 (NCRP 1984a), Radiological Assessment
(Till and Meyer 1983), and in the Background
Information Document for the Draft EIS for